Incorporated in 1999, Ikonisys is a diagnostic firm developing instruments and software for oncology/ cancer and prenatal testing/ applications. It operates in the highly concentrated c.$69bn global in-vitro diagnostic (IVD) market (dominated by heavyweights like Roche Diagnostics, Abbot Laboratories and Siemens) and is trying to establish its niche in the two segments of the market – FISH (fluorescence in situ hybridisation; market size: $1.2bn) and CTC (circulating tumour cells; market size: $0.5bn).

Fundamental analysis

Retour haut de page